Incyte
INCY
#1159
Rank
$20.14 B
Marketcap
$102.60
Share price
1.66%
Change (1 day)
38.42%
Change (1 year)

Market capitalization of Incyte (INCY)

Market cap: $20.14 Billion USD

As of February 2026 Incyte has a market cap of $20.14 Billion USD. This makes Incyte the world's 1159th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Incyte from 1996 to 2026

End of year Market Cap

Year Marketcap Change
2026$20.14 B2.49%
2025$19.65 B47.36%
2024$13.33 B-5.22%
2023$14.07 B-21.25%
2022$17.86 B10.21%
2021$16.21 B-14.88%
2020$19.04 B0.91%
2019$18.87 B39.19%
2018$13.56 B-32.15%
2017$19.98 B5.81%
2016$18.88 B-6.68%
2015$20.24 B62.03%
2014$12.49 B51.39%
2013$8.25 B272.24%
2012$2.21 B16.93%
2011$1.89 B-7.14%
2010$2.04 B88.49%
2009$1.08 B194.1%
2008$0.36 B-56.65%
2007$0.84 B73.24%
2006$0.49 B9.85%
2005$0.44 B-46.18%
2004$0.82 B67.15%
2003$0.49 B61.98%
2002$0.30 B-76.39%
2001$1.29 B-20.6%
2000$1.63 B-5.73%
1999$1.73 B66.64%
1998$1.04 B-3.9%
1997$1.08 B101.17%
1996$0.53 B

End of Day market cap according to different sources

On Feb 4th, 2026 the market cap of Incyte was reported to be:

$20.14 Billion USD
by Nasdaq info icon info icon
$20.14 Billion USD
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
$293.40 B 1,356.62%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
$152.26 B 655.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$992.48 B 4,827.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$197.38 B 879.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
$3.90 B-80.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
$0.93 B-95.34%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
$1.19 B-94.05%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
$0.52 B-97.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
$1.79 B-91.10%๐Ÿ‡บ๐Ÿ‡ธ USA